Lightnews — Scholar-powered news

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · 3d

Ontario to offer early access to some new cancer drugs in pilot project

Meanwhile, national public insurance body vows to speed up price negotiations – possibly eliminating the need for the pilot project

www.theglobeandmail.com

3 5 7

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · 9d

Canadian virtual pharmacy PurposeMed expands Freddie HIV treatment to all 50 U.S. states

Freddie currently provides pre-exposure prophylaxis, or PrEP, to 13,500 patients

www.theglobeandmail.com

4 5 12

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · 17d

Health startup founded by Canadians expands AI-powered dementia treatment, raises more funding

Moneta Health announced Tuesday it had raised US$4.5-million from several investors including the Ontario Teachers’ Pension Plan and BKR Capital

www.theglobeandmail.com

4 3 6

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · 21d

Moderna to roll out first made-in-Canada COVID-19 vaccines this fall

Facilities in Laval, Que., and Cambridge, Ont. producing U.S. drugmaker’s mRNA vaccines

www.theglobeandmail.com

5 54 160

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · 22d

Novo Nordisk partners with Pocketpills for online sales of Ozempic, Wegovy

Pocketpills operates four fulfilment centres across Canada to deliver medications in all provinces except Quebec

www.theglobeandmail.com

4 1 2

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Sep 4

Health Canada says it is working to reduce backlog of lower-cost biosimilar drug submissions

www.theglobeandmail.com

1 3 11

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Sep 3

Manulife is steering Wegovy and Mounjaro patients to Shoppers pharmacies

The insurer has been directing patients to pharmacies owned by Loblaw, despite facing backlash for its preferred provider networks deals with the retailer

www.theglobeandmail.com

2 7 4

Reposted by Chris Hannay

Canada Healthwatch 🍁 @canadahealthwatch.ca · Aug 26

Untangling the Information Ecosystem — Health, Media, and the Public (Guests: @hannay.bsky.social & @nicktsergas.ca)
podcasts.apple.com/ca/podcast/u...

Untangling the Information Ecosystem - Health, Media, and the Public

Podcast Episode · Digital Health in Canada · 2025-08-25 · 41m

podcasts.apple.com

1 5 9

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 26

Specialty pharmacy chain SRx files for creditor protection after unsuccessful roll-up strategy

At the time of its application to the Ontario Superior Court of Justice on Aug. 12, SRx operated 17 specialty pharmacies and 19 clinics across Canada

www.theglobeandmail.com

3 1 2

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 21

How a new mental-health app is helping patients reality-check their hallucinations

A4i aims to help patients by providing coping strategies, documenting moods and preventing crises

www.theglobeandmail.com

2 6 8

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 14

Eli Lilly hikes weight-loss drug prices in Canada after pressure from Trump

Trump administration demands lower prices in the U.S., forcing the pharmaceutical company to raise them in other markets

www.theglobeandmail.com

6 6 8

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 13

Conservatives call for investigation of Spanish drugmakers’ use of Canadian-donated blood plasma

The Globe and Mail previously found that Canadian Blood Services is selling some blood components to Grifols

www.theglobeandmail.com

5 3

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 12

Spanish drugmaker using Canadian-donated blood plasma for products sold abroad

Canadian Blood Services had pledged that all blood donations would be used for products that stay in Canada

www.theglobeandmail.com

2 5 12

Reposted by Chris Hannay

Canada Healthwatch 🍁 @canadahealthwatch.ca · Aug 7

Speeding up drug approval timelines a priority, health minister says www.theglobeandmail.com/business/eco... @hannay.bsky.social

𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁

Minister of Health Marjorie Michel says one way to speed up drug approval timelines is earlier screening of applications.

4 7

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 6

Speeding up drug approval timelines a priority, health minister says

Liberals promised to ‘significantly reduce’ wait times for pharmaceuticals, which it acknowledged were longer than in other Group of Seven countries

www.theglobeandmail.com

2 1 8

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 6

Some Wegovy prescriptions redirected to pharmacies that signed exclusive deals with insurers

It’s the most high-profile example yet of a controversial industry practice called preferred pharmacy networks, or PPNs

www.theglobeandmail.com

3 5

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 5

Health Canada taking longer to approve generic drugs, data show

Delays in the approval process mean it takes longer for cheaper drugs to reach the market

www.theglobeandmail.com

3 8

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Aug 1

Trump demands drug companies lower prices in U.S. and raise them in other countries

White House has issued letters to 17 pharma giants, giving them 60 days to take action

www.theglobeandmail.com

4 11 11

Reposted by Chris Hannay

Canada Healthwatch 🍁 @canadahealthwatch.ca · Jul 11

Potential U.S. tariffs, pricing rules raise uncertainty in drug industry www.theglobeandmail.com/business/art... @hannay.bsky.social

𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁

Only a small amount of pharmaceuticals consumed in the U.S. are fully produced there with a recent analysis showing 12 per cent of active ingredients made there.

1 4

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Jul 9

Generic version of Ozempic, Wegovy to launch in Canada by Hims & Hers

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for approval to make generic drug

www.theglobeandmail.com

2 6 10

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Jul 7

Stake sale of Humber Valley Imaging reflects shift in industry competition

The family-owned clinics which see about 150,000 patients annually has had to adapt its strategy to level with competitors

www.theglobeandmail.com

3 1

Reposted by Chris Hannay

Tu Thanh Ha @tuthanhha.bsky.social · Jul 4

He cut his hand badly when it hit a chainsaw. But when he showed up at the local ER, he found it was closed for the day.
That's the new reality in many rural Canadian hospitals that no longer have 24/7 ER services.
We took a deep dive and analyzed the data.
www.theglobeandmail.com/canada/artic...

2 33 47

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Jul 2

Federal drug-price regulator unveils new guidelines for 2026

Guidelines aimed at increasing transparency about how the regulator will evaluate pharmaceutical pricing, official says

www.theglobeandmail.com

1 2 3

Reposted by Chris Hannay

The Globe and Mail @theglobeandmail.com · Jun 30

CAMH Youth Wellness Hubs work to streamline medical records for young visitors

Within Canada’s deeply fragmented medical records system, YWHO have created their own methods to provide youth with accessible care

www.theglobeandmail.com

2 2 1

Reposted by Chris Hannay

André Picard @picardonhealth @picardonhealth.bsky.social · Jun 20

23andMe probe highlights Canadian Privacy Commissioner’s lack of powers compared to U.K counterpart. U.K. levied $4.26-million fine against company. Canada has no authority to do so, by @hannay.bsky.social www.theglobeandmail.com/business/eco... via @theglobeandmail.com

23andMe probe highlights Privacy Commissioner’s lack of powers compared to U.K counterpart

Philippe Dufresne, who has advocated for more authority since his appointment in 2022, was unable to levy a fine against the company

www.theglobeandmail.com

1 20 65